TWI357823B - Solid dosage forms of combination medicine for tre - Google Patents
Solid dosage forms of combination medicine for tre Download PDFInfo
- Publication number
- TWI357823B TWI357823B TW98136960A TW98136960A TWI357823B TW I357823 B TWI357823 B TW I357823B TW 98136960 A TW98136960 A TW 98136960A TW 98136960 A TW98136960 A TW 98136960A TW I357823 B TWI357823 B TW I357823B
- Authority
- TW
- Taiwan
- Prior art keywords
- tre
- solid dosage
- dosage forms
- combination medicine
- medicine
- Prior art date
Links
- 239000007909 solid dosage form Substances 0.000 title description 3
- 239000003814 drug Substances 0.000 title 1
- 239000004480 active ingredient Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000007908 dry granulation Methods 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Description
(V)潤滑劑。 中華民國發明專利第1357823號 發明專利更正後無劃線之申請專利範圍替货本(2015年1月5曰) 3雜本 9·根據申請專利範圍第8項之固體劑型,其中在所述 製造方法之(a)步驟中’該活性成份以及組份(i)至(iv)係 以乾式造粒法製成顆粒性粉末,再加入組份(v)置入至適當的 混合容器内均勻混合以形成混合物。 10.根據申請專利範圍第8項之固體劑型,其中在所述 製造方法之(a)步驟中,該活性成份以及組份(i)至(iv)係 以嗔霧造粒法製成顆粒性粉末,再加入組份(v)置入至適當的' 混合谷器内均勻混合以形成混合物。(V) Lubricant. The invention patent of the Republic of China invention patent No. 1357823 is corrected after the application of the scope of the patent without the scribe line (January 5, 2015) 3 Miscellaneous 9. The solid dosage form according to item 8 of the patent application, wherein the manufacture In the step (a) of the method, the active ingredient and the components (i) to (iv) are prepared into a granular powder by a dry granulation method, and then the component (v) is placed in a suitable mixing container and uniformly mixed. To form a mixture. 10. The solid dosage form according to item 8 of the patent application, wherein in the step (a) of the manufacturing method, the active ingredient and the components (i) to (iv) are made into a granular form by haze granulation. The powder, which is then added to the component (v), is placed in a suitable 'mixed barr' and uniformly mixed to form a mixture.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW98136960A TWI357823B (en) | 2003-11-27 | 2003-11-27 | Solid dosage forms of combination medicine for tre |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW98136960A TWI357823B (en) | 2003-11-27 | 2003-11-27 | Solid dosage forms of combination medicine for tre |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201023915A TW201023915A (en) | 2010-07-01 |
TWI357823B true TWI357823B (en) | 2012-02-11 |
Family
ID=44851804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW98136960A TWI357823B (en) | 2003-11-27 | 2003-11-27 | Solid dosage forms of combination medicine for tre |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWI357823B (en) |
-
2003
- 2003-11-27 TW TW98136960A patent/TWI357823B/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TW201023915A (en) | 2010-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2413698A1 (en) | Endoparasiticidal agents for voluntary oral ingestion by animals | |
MX2007010541A (en) | Compositions and methods of making sustained release liquid formulations. | |
CN1296412A (en) | Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants | |
ATE470443T1 (en) | INDOL-1-YL ACID DERIVATIVES | |
WO2001027109A3 (en) | Tert.-butyl-(7-methyl-imidazo[1,2-a]pyridine-3-yl)-amine derivatives | |
HK1115308A1 (en) | Solid dosage form comprising proton pump inhibitor and suspension made thereof | |
WO2005041925A3 (en) | Compositions and dosage forms for enhanced absorption | |
MY136524A (en) | New solid pharmaceutical formulations comprising telmisartan and preparation thereof | |
WO2005107721A3 (en) | Pharmaceutical dosage form comprising pellets as well as its manufacturing process | |
WO2004112719A8 (en) | Chemical compounds | |
WO2006125620A3 (en) | Cores and microcapsules suitable for parenteral administration as well as process for their manufacture | |
WO2006070325A3 (en) | 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists | |
NZ710384A (en) | A novel formulation of indomethacin | |
WO2007093880A3 (en) | Novel pyrone-indole derivatives and process for their preparation | |
SI2729130T1 (en) | Darunavir combination formulations | |
DE60211769D1 (en) | A process for the preparation of drug granules, the drug granules and pharmaceutical compositions containing them | |
MX2008001560A (en) | Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds. | |
ATE442852T1 (en) | DELAYED-RELEASE MEDICINAL COMPRISING TRIMETAZIDINE AND METHOD FOR THE PRODUCTION | |
TW201206453A (en) | New use of diatomaceous earth in the pharmaceutical industry | |
DE602005024554D1 (en) | PHARMACEUTICAL COMPOSITION WITH AMLODIPIN BESILATE AND LISINOPRILED DIHYDRATE AND METHOD OF MANUFACTURING THEREOF | |
ATE459342T1 (en) | STABILIZED SOLID MEDICINAL FORMS CONTAINING ACTIVE INGREDIENT AND TRIMAGNESIUM DICITRATE AS DESICCANTS AND METHOD FOR THE PRODUCTION THEREOF | |
TWI357823B (en) | Solid dosage forms of combination medicine for tre | |
JP2009513165A5 (en) | ||
ATE419838T1 (en) | PHARMACEUTICAL PREPARATION FORM OF ALIPHATIC AMINE POLYMERS AND METHOD FOR THE PRODUCTION THEREOF | |
DE50204789D1 (en) | NEW 1-AMIDOMETHYL CARBONYL-PIPERIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THESE COMPOUNDS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4A | Expiration of patent term of an invention patent |